Research Article
Response Surface Optimization of Sustained Release Metformin-Hydrochloride Matrix Tablets: Influence of Some Hydrophillic Polymers on the Release
Table 1
Formulation design of Met-HCl matrix tablets.
| Sl. no. | Ingredients (mg) | Formulation | FF1 | FF2 | FF3 | FF4 | FF5 | FF6 |
| 1 | Metformin HCl | 500 | 500 | 500 | 500 | 500 | 500 | 2 | Microcrystalline cellulose | 101 | 100.2 | 99.3 | 98.4 | 97.5 | 96.6 | 3 | HPMC K4M (X1) | 103.8 | 102.9 | 102 | 101.2 | 100.3 | 99.4 | 4 | HPMC K100M (X2) | 145.2 | 146.9 | 148.7 | 150.4 | 152.2 | 154 | 5 | Povidone K30 | 20 | 20 | 20 | 20 | 20 | 20 | 6 | Magnesium stearate | 5 | 5 | 5 | 5 | 5 | 5 | 7 | Talc | 5 | 5 | 5 | 5 | 5 | 5 |
|
|